EMILY GREENLEE: Open Payments
NPI 1639575376 · ALBEMARLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 28 payments from 11 companies in 2025. Trend: 2023 $429 · 2024 $522 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $94 |
| Lilly USA, LLC | 4 | $74 |
| Exact Sciences Corporation | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: Kerendia, FARXIGA, MOUNJARO, The Cologuard Plus Collection Kit, AIRSUPRA, ZEPBOUND, VOQUEZNA, REXULTI.
Industry payments across NC — which companies pay providers there.
